Rituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reports

Por Evens, A. M., Jovanovic, B. D., Su, Y.-C., Raisch, D. W., Ganger, D., Belknap, S. M., Dai, M.-S., Chiu, B.-C. C., Fintel, B., Cheng, Y., Chuang, S.-S., Lee, M.-Y., Chen, T.-Y., Lin, S.-F., Kuo, C.-Y.
Publicado em 2011